Why not join the Living with metastatic private group? Access group via the link here.

Enhertu now on PBS list for MBC patients

Options
arpie
arpie Member Posts: 7,600 ✭
in Metastatic breast cancer
GREAT NEWS

BCNA welcomes the listing of Enhertu (trastuzumab deruxtecan) on the Pharmaceutical Benefits Scheme (PBS) for those with metastatic breast cancer.

BCNA supported the process for Enhertu to be considered for listing on the PBS and we welcome the government subsidy for this exciting new drug.
“This is a significant step towards achieving greater equity of access for a life prolonging drug like Enhertu,” says BCNA director Policy, Advocacy & Support Services Vicki Durston.
Enhertu is listed on the PBS to treat patients who have been diagnosed with metastatic human epidermal growth factor receptor 2 (HER2) positive breast cancer as of 1 November.

Read about the Australian Government’s announcement of the listing of Enhertu on the PBS here:
https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/new-treatment-for-women-battling-aggressive-breast-cancer-0

If you have any questions about Enhertu we encourage you to speak to your treating team.

Tagged:

Categories